Changes to the Controlled Drug and Substances Act (CDSA) with respect to the marketing, sales and distribution of prescription drug products.
Regulation
All controlled-release oxycodone products approved/sold in Canada, in all strengths, should be demonstrated to be abuse-deterrent and the Regulations under the Controlled Drugs and Substances Act should be drafted
to make this a requirement for the pre-market approval or the continuation of existing market approval of these products.